EODData

MEMBERSHIP REGISTER LOG IN

FRA, R5XA: ACELRX PHARMACEUT. DL-01

04 Sep 2026
LAST:

1.010

CHANGE:
 0.00		OPEN:
1.010		HIGH:
1.010		ASK:
0.000		VOLUME:
0
CHG(%):
0.00		PREV:
1.010		LOW:
1.010		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Sep 261.0101.0101.0101.0100
03 Sep 261.0101.0101.0101.0100
02 Sep 260.9950.9950.9950.9950
31 Aug 261.0101.0101.0101.0100
27 Aug 261.0601.0601.0601.0600
26 Aug 261.0301.0301.0301.0300
25 Aug 261.0001.0001.0001.0000
24 Aug 260.9950.9950.9950.9950
21 Aug 260.9950.9950.9950.9950
20 Aug 261.0001.0001.0001.0000

PROFILE

Name:ACELRX PHARMACEUT. DL-01
About:Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Sector:Healthcare
Address:1850 Gateway Drive, San Mateo, CA, United States, 94404
Website:https://talphera.com
ISIN:US00444T2096

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:0.17 
PEG Ratio:0.00 
Price to Sales:51,646.27 
Price to Book:3.12 
Operating Margin:-14,747.00 
Return on Assets:-0.43 
Return on Equity:-1.43 
Revenue:854 
Shares:20.5M 
Market Cap:20.71M 

TECHNICAL INDICATORS

MA5:1.020.7%
MA10:1.010.0%
MA20:1.064.9%
MA50:1.054.2%
MA100:0.8716.1%
MA200:0.8716.0%
STO9:23.08
STO14:23.08
RSI14:28.57 
WPR14:-76.92
MTM14:-0.01
ROC14:-0.01 
ATR:0.03 
Week High:1.010.0%
Week Low:1.001.5%
Month High:1.2523.8%
Month Low:1.0016.0%
Year High:1.2523.8%
Year Low:0.43132.7%
Volatility:50.82 

RECENT SPLITS

Date Ratio
26 Oct 20221-20